News

French IT major Capgemini will acquire Indian-origin BPO firm WNS in a $3.3 billion cash deal. This and more in todays ETtech ...
Mack Roach III, MD, discusses the development and evaluation of a multimodal AI algorithm designed to predict prostate cancer ...
The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...
See the latest ADMA Biologics Inc stock price (ADMA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Current guidelines suggest limiting diagnostic testing for chronic spontaneous urticaria when no clear cause is suspected, though biomarkers and biopsies are emerging as tools to predict treatment ...
Recommended management of asthma, including appropriate diagnostic steps and use of fractional exhaled nitric oxide (FeNO) in ...
The Hong Kong-listed firm is advancing its pipeline using an mRNA system it says can compete with the industry’s best.
Arsenale Bioyards recognized the inefficiencies and developed a platform that could radically change biomanufacturing, much like the Bessemer converter in the mid-19th century transformed the steel ...
Ensuring sustainability in biologics production Although biologics present an exciting opportunity for drugmakers to enter a burgeoning field of innovation, sustainability remains a core issue for ...
Biologics manufacturing often requires highly specialised knowledge, equipment, and facilities that can be challenging for pharmaceutical companies to maintain in-house.
The growth of the complicated urinary tract infections market is expected to be mainly driven by the entry of new therapies such as Tebipenem Pivoxil Hydrobromide (SPR994), ZAYNICH ...